Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program
- PMID: 20185513
- PMCID: PMC2854047
- DOI: 10.1093/humrep/deq046
Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program
Abstract
Background: Recent advancement of minimum volume vitrification methods has resulted in a dramatic increase in the efficiency of the process. The aim of this study was to estimate the cumulative reproductive outcome of a cohort of infertile couples undergoing ICSI and oocyte vitrification in restrictive legal conditions, where only a limited number of oocytes could be inseminated per cycle and embryo selection and cryopreservation were forbidden.
Methods: In this prospective longitudinal cohort study, the cumulative ongoing pregnancy rates obtained by the insemination of fresh and vitrified oocytes from the same cohort were calculated as primary outcome measures. Moreover, the effect of basal and cycle characteristics on clinical outcomes were assessed.
Results: Between September 2008 and May 2009, 182 ICSI cycles were performed where oocyte vitrification was possible. A total of 104 first and 11 second oocyte warming cycles were then performed in non-pregnant patients of the same cohort. The overall ongoing pregnancy rates obtained in the fresh, and first and second warming cycles were 37.4, 25.0 and 27.3%, respectively. The overall cumulative ongoing clinical pregnancy rate observed per stimulation cycle was 53.3%. Maternal age was the only characteristic found to influence the reproductive outcome, with an inverse correlation between the age >40 and the ongoing pregnancy rates (P = 0.04, by Cox regression analysis).
Conclusions: High cumulative ongoing pregnancy rates can be obtained with transfers of embryos derived from fresh and cryopreserved oocytes in a typical infertile population. Female age significantly affects outcomes in this system.
Similar articles
-
Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study.Hum Reprod. 2010 Jan;25(1):66-73. doi: 10.1093/humrep/dep346. Epub 2009 Oct 27. Hum Reprod. 2010. PMID: 19861328 Free PMC article. Clinical Trial.
-
Efficiency and efficacy of vitrification in 35 654 sibling oocytes from donation cycles.Hum Reprod. 2020 Oct 1;35(10):2262-2271. doi: 10.1093/humrep/deaa178. Hum Reprod. 2020. PMID: 32856058
-
A prospective pilot study comparing fertilization and embryo development between fresh and vitrified sibling oocytes.Conn Med. 2013 Apr;77(4):211-7. Conn Med. 2013. PMID: 23691734 Clinical Trial.
-
Fresh oocyte cycles yield improved embryo quality compared with frozen oocyte cycles in an egg-sharing donation programme.Zygote. 2021 Jun;29(3):234-238. doi: 10.1017/S0967199420000842. Epub 2021 Jan 18. Zygote. 2021. PMID: 33455591 Review.
-
Clinical utility of freeze-all approach in ART treatment: A mini-review.Cryobiology. 2020 Feb 1;92:9-14. doi: 10.1016/j.cryobiol.2019.11.041. Epub 2019 Nov 23. Cryobiology. 2020. PMID: 31770530 Review.
Cited by
-
The Effect of Freezing Twice during Assisted Reproductive Technology on Perinatal and Neonatal Outcomes.Biomed Res Int. 2022 Apr 4;2022:5623462. doi: 10.1155/2022/5623462. eCollection 2022. Biomed Res Int. 2022. PMID: 35419457 Free PMC article.
-
Autologous oocyte cryopreservation in women aged 40 and older using minimal stimulation IVF.Reprod Biol Endocrinol. 2015 Oct 6;13:112. doi: 10.1186/s12958-015-0110-4. Reprod Biol Endocrinol. 2015. PMID: 26444973 Free PMC article.
-
Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance.Hum Reprod Update. 2017 Mar 1;23(2):139-155. doi: 10.1093/humupd/dmw038. Hum Reprod Update. 2017. PMID: 27827818 Free PMC article.
-
Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis.Fertil Steril. 2013 Aug;100(2):492-9.e3. doi: 10.1016/j.fertnstert.2013.04.023. Epub 2013 May 24. Fertil Steril. 2013. PMID: 23706339 Free PMC article.
-
Effects of new synthetic cryoprotectant agents on histological characteristics of various classes of vitrified bovine pre-antral follicles.Vet Res Forum. 2019 Winter;10(1):9-16. doi: 10.30466/vrf.2019.34306. Epub 2019 Mar 15. Vet Res Forum. 2019. PMID: 31183010 Free PMC article.
References
-
- Antinori M, Licata E, Dani G, Cerusico F, Versaci C, Antinori S. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod Biomed Online. 2007;14:72–79. - PubMed
-
- Arav A. Vitrification of oocytes and embryos. In: Lauria A, Gandolfi F, editors. New Trends in Embryo Transfer. Cambridge: Portland Press; 1992. pp. 255–264.
-
- Benagiano G, Gianaroli L. The new Italian IVF legislation. Reprod Biomed Online. 2004;9:117–125. - PubMed
-
- Boldt J, Tidswell N, Sayers A, Kilani R, Cline D. Human oocyte cryopreservation: 5-year experience with a sodium-depleted slow freezing method. Reprod Biomed Online. 2006;13:96–100. - PubMed
-
- Borini A, Bonu MA, Coticchio G, Bianchi V, Cattoli M, Flamigni C. Pregnancies and births after oocyte cryopreservation. Fertil Steril. 2004;82:601–605. - PubMed